Summaries for patients. Cost-effectiveness of screening and surveillance for Barrett esophagus.
D000230:Adenocarcinoma / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology; D001471:Barrett Esophagus / Q000175:diagnosis* / Q000209:etiology; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D004938:Esophageal Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology; D004947:Esophagus / Q000473:pathology; D005764:Gastroesophageal Reflux / Q000150:complications*; D006801:Humans; D008297:Male; D008390:Markov Chains; D008403:Mass Screening / Q000191:economics*; D008875:Middle Aged; D009010:Monte Carlo Method; D011159:Population Surveillance; D011230:Precancerous Conditions / Q000175:diagnosis* / Q000209:etiology; D019057:Quality-Adjusted Life Years; D012307:Risk Factors; D012680:Sensitivity and Specificity